09/12/2026
Out Now! Ahead of the 11th Annual CAR-TCR Summit, our SVP of Clinical Development & CMC, Pei Wang, sat down with Brad Watts, CAR-T recipient and patient advocate with the Emily Whitehead Foundation, for a conversation on what it's like to receive CAR-T therapy, and why making that information accessible matters.
They also touched upon the future of CAR-T therapy, and how companies like Eureka Therapeutics are working to get there.
🔗Watch the full conversation here: https://www.linkedin.com/posts/car-tcr-summit-event-series_as-the-countdown-to-the-%F0%9D%9F%AD%F0%9D%9F%AD%F0%9D%98%81%F0%9D%97%B5-%F0%9D%97%96%F0%9D%97%94%F0%9D%97%A5-%F0%9D%97%A7%F0%9D%97%96%F0%9D%97%A5-activity-7503440830490292225-nJAq?utm_source=share&utm_medium=member_desktop&rcm=ACoAAC8jWp8Bnpd8o7Ps1Q92TPrz6DmKBMatChM
To learn more about our mission and pipeline, visit www.eurekatherapeutics.com
As the countdown to the 𝟭𝟭𝘁𝗵 𝗖𝗔𝗥-𝗧𝗖𝗥 𝗦𝘂𝗺𝗺𝗶𝘁 enters its final days, we're excited to share the second half of this powerful conversation between Pei Wang, Bringing hope, Senior Vice President, Clinical Development & CMC at Eureka Therapeutics, Inc, and ...